Q3 2020

Filed Nov 9, 2020 · 10-Q · 40 days after period end · 0000877860-20-000100

Q3 2020 · 10-Q

Revenue

$84.30M

+3.2% vs Q3 2019

Net Income

$42.60M

−0.4% vs Q3 2019

EPS Diluted

$0.95

−2.1% vs Q3 2019

Margins · derived

Net margin50.5%−1.8 pt vs Q3 2019

Same quarter

Metric	Q3 2020	Q3 2019	Q3 2018	Q3 2017
Revenue	$84.30M	$81.68M	$74.92M	$71.35M
Net Income	$42.60M	$42.76M	$40.98M	$39.09M
EPS Diluted	$0.95	$0.97	$0.97	$0.94

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

National Health Investors Inc · CIK 877860 · Engraved from SEC EDGAR